The present disclosure generally pertains to systems and methods for the treatment of cancer. Disclosed herein are compositions for the treatment of cancer, such compositions comprising a plurality of gold nanoparticles coated with citrate ions, frankincense and myrrh. Also disclosed herein are methods for the treatment of cancer, such methods comprising the administration of a plurality of gold nanoparticles coated with citrate ions, frankincense and myrrh.

Moses; Sherita L.

Alabama A&amp;M University

Drug delivery systems and methods for treating cancer using gold nanoparticles coated with citrate ions, frankincense and myrrh

The invention describes a nutraceutical composition and method for preventing/treating cancer or augmenting chemotherapy in advanced stage malignancies; comprised of [1] tumoricidal herbs; beth root, galbanum, gromwell root, wild yam, balm of gilead bud, frankincense, [2] an antiproliferative herb; speranskia [3] a natural lactic acid dehydrogenase (LDH) inhibitor, 2',3,4'5,7-pentahydroxyflavone or cinnamon, [4] alkalizing agents: calcium, magnesium, potassium or bicarbonate salts, barley grass, chlorella and spirulina [5] at least one quinone and [6] at least one agent capable of maximizing oxidative mitochondrial function preferably riboflavin, 6,7-Dimethyl-8-(1-D-ribityl)lumazine, ribitol, 5,6-dimethylbenzimidazole, tetrahydrobiopterin and a pharmaceutically acceptable carrier.

Mazzio; Elizabeth Anne

Soliman; Karam F

Florida Agricultural and Mechanical University

Herbal composition and method of use for the treatment of cancer

A complex prescription of Chinese medicine for the treatment of extensive cancer, or cancer of relation type of the lymph node. The ingredients of this complex prescription are Pilose asiabell root, Astragalus root, Coix seed, Eupatorium, Tangerine peel, Justicia, Prunella spike, Serissa serissoides, Capejasmine fruit, Forsythia fruit, Red peony root, Rhubarb, Blister beetle, Oldenlandia, Polygonum perfoliatum, Subprostrate sophora root, Shrubalthea bark, Rhizome of arisaema, Chinese Lobelia, Ampelopsis, Globethistle, Pyrrosia leaf, Frankincense, Myrrh, Paris chinensis franch, Patrinia, Dahurian angelica root, Belamcanda rhizome, Dandelion herb, Lemmaphyllum microphyllum, Gleditsia spine, Pubescent angelica root, Chinese Ephedra, and Cimicifuga rhizome. The extraction is improved and it also adopts Indian Bread (Poria), an effective cancer medicine, as excipient.

Complex prescription of chinese medicine for the treatment of extensive cancer

The invention relates to Boswellia frereana and particularly an extract of same for treating a range of inflammatory disorder or conditions selected from the group comprising: articular cartilage degradation or arthritides, osteoarthritis, rheumatoid arthritis, inflammatory bowel disease (IBD), all forms of muscular dystrophy especially Duchenne muscular dystrophy, sepsis, sepsis syndrome, osteoporosis, ischemic injury, graft vs. host disease, reperfusion injury, asthma, diabetes, cancer, myelogenous and other leukemias, psoriasis and cachexia, Alzheimer's Disease, demyelinating neurological disorders including multiple sclerosis, Acetylcholinesterase mediated disorders, retinal disorders, neurological, retinal, and muscular disorders.

boswellia sacra/nowotwór złośliwy

Drug delivery systems and methods for treating cancer using gold nanoparticles coated with citrate ions, frankincense and myrrh

Herbal composition and method of use for the treatment of cancer

Complex prescription of chinese medicine for the treatment of extensive cancer

Inhibitor of inflammatory conditions

Najbardziej kompletna baza danych ziół leczniczych poparta naukowo